Tekla Capital Management LLC Sage Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$40.26 - $57.37 $4.59 Million - $6.55 Million	-114,119 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$70.65 - $96.76 $2.68 Million - $3.67 Million	-37,921 Reduced 24.94%	114,119 $8.54 Million
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $3.26 Million - $4.97 Million	55,829 Added 58.03%	152,040 $13.2 Million
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $567,557 - $1.46 Million	9,431 Added 10.87%	96,211 $6.95 Million
Q3 2019 Nov 13, 2019	BUY	$140.29 - $189.96 $369,664 - $500,544	2,635 Added 3.13%	86,780 $12.2 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $677,018 - $785,273	4,289 Added 5.37%	84,145 $15.4 Million
Q1 2019 May 14, 2019	SELL	$89.33 - $163.65 $1.66 Million - $3.04 Million	-18,588 Reduced 18.88%	79,856 $12.7 Million
Q4 2018 Feb 13, 2019	SELL	$81.94 - $139.71 $3.7 Million - $6.31 Million	-45,170 Reduced 31.45%	98,444 $9.43 Million
Q2 2018 Aug 13, 2018	BUY	$140.36 - $175.76 $2.66 Million - $3.33 Million	18,964 Added 15.21%	143,614 $22.5 Million
Q1 2018 May 14, 2018	BUY	$152.15 - $192.33 $8.65 Million - $10.9 Million	56,835 Added 83.81%	124,650 $20.1 Million
Q4 2017 Feb 14, 2018	BUY	$60.72 - $167.34 $4.12 Million - $11.3 Million	67,815 New	67,815 $11.2 Million
Q3 2017 Nov 13, 2017	SELL	$61.4 - $88.52 $5.56 Million - $8.01 Million	-90,480 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	90,480	90,480 $7.21 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $395M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.